NuVasive Receives Premarket Approval of Cervical Spine Disc System

NuVasive has received premarket approval of its PCM Cervical Disc System from the FDA.

Advertisement

The PCM Cervical Disc is indicated for use in skeletally mature patients for reconstruction of a degenerated cervical disc at one level from C3-C4 to C6-C7. The device is implanted using an anterior approach. Patients should have failed at least six weeks of conservative treatment prior to implantation.

More Articles on Orthopedic Devices:

New Instrumentation & Partnership for DePuy Synthes Spine
DePuy Synthes Spine Launches Minimally Invasive Posterior-Lateral Fusion System
10 Orthopedic Device Company Acquisitions

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.